Literature DB >> 31738866

Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2018: the Influenza Complications Alert Network (FluCAN).

Allen C Cheng1, Mark Holmes2, Dominic E Dwyer3, Sanjaya Senanayake4, Louise Cooley5, Louis B Irving6, Graham Simpson7, Tony Korman8, Kristine Macartney9, N Deborah Friedman10, Peter Wark11, Anna Howell12, Christopher C Blyth13, Nigel Crawford14, Jim Buttery15, Simon Bowler16, John W Upham17, Grant W Waterer18, Tom Kotsimbos1, Paul M Kelly19.   

Abstract

The Influenza Complications Alert Network (FluCAN) is a sentinel hospital-based surveillance program that operates at sites in all jurisdictions in Australia. This report summarises the epidemiology of hospitalisations with laboratory-confirmed influenza during the 2018 influenza season. In this observational surveillance system, cases were defined as patients admitted to any of the 17 sentinel hospitals with influenza confirmed by nucleic acid detection. Data were also collected on a frequency-matched control group of influenza-negative patients admitted with acute respiratory infection. During the period 3 April to 31 October 2018 (the 2018 influenza season), 769 patients were admitted with confirmed influenza to one of 17 FluCAN sentinel hospitals. Of these, 30% were elderly (≥65 years), 28% were children (<16 years), 6.4% were Aboriginal and Torres Strait Islander peoples, 2.2% were pregnant and 66% had chronic comorbidities. A small proportion of FluCAN admissions were due to influenza B (13%). Estimated vaccine coverage was 77% in the elderly (≥65 years), 45% in non-elderly adults with medical comorbidities and 26% in children (<16 years) with medical comorbidities. The estimated vaccine effectiveness (VE) in the target population was 52% (95% CI: 37%, 63%). There were a smaller number of hospital admissions detected with confirmed influenza in this national observational surveillance system in 2018 than in 2017, with the demographic profile reflecting the change in circulating subtype from A/H3N2 to A/H1N1. © Commonwealth of Australia CC BY-NC-ND.

Entities:  

Keywords:  zzm321990 Influenzazzm321990 ; zzm321990 influenza vaccineszzm321990 ; zzm321990 public health surveillancezzm321990 ; zzm321990 vaccination coveragezzm321990 ; zzm321990 vaccine effectivenesszzm321990

Mesh:

Substances:

Year:  2019        PMID: 31738866     DOI: 10.33321/cdi.2019.43.48

Source DB:  PubMed          Journal:  Commun Dis Intell (2018)        ISSN: 2209-6051


  6 in total

1.  Clinical characteristics and outcomes of influenza A and B virus infection in adult Australian hospitalised patients.

Authors:  Yogesh Sharma; Chris Horwood; Paul Hakendorf; Campbell Thompson
Journal:  BMC Infect Dis       Date:  2020-12-01       Impact factor: 3.090

2.  Respiratory virus detection during the COVID-19 pandemic in Queensland, Australia.

Authors:  Asmaa El-Heneidy; Robert S Ware; Jennifer M Robson; Sarah G Cherian; Stephen B Lambert; Keith Grimwood
Journal:  Aust N Z J Public Health       Date:  2021-10-14       Impact factor: 3.755

3.  Clinical and molecular epidemiology of influenza viruses from Romanian patients hospitalized during the 2019/20 season.

Authors:  Victor Daniel Miron; Leontina Bănică; Oana Săndulescu; Simona Paraschiv; Marius Surleac; Dragoș Florea; Ovidiu Vlaicu; Petre Milu; Anca Streinu-Cercel; Anuta Bilașco; Dan Oțelea; Daniela Pițigoi; Adrian Streinu-Cercel; Anca Cristina Drăgănescu
Journal:  PLoS One       Date:  2021-11-12       Impact factor: 3.240

4.  The Pendulum Has Swung: How Do We Ensure a Life Course Approach to Immunisation in Australia?

Authors:  Holly Seale; Kathleen McFadden; Amalie Dyda; Jessica Kaufman; Anita Heywood
Journal:  Front Public Health       Date:  2022-02-04

5.  Pandemic treatments on trial: the bigger picture. N of many thinking in an N of one scenario.

Authors:  Tom Kotsimbos; Marc Humbert
Journal:  Eur Respir J       Date:  2020-09-17       Impact factor: 16.671

6.  Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020.

Authors:  Sheena G Sullivan; Sandra Carlson; Allen C Cheng; Monique Bn Chilver; Dominic E Dwyer; Melissa Irwin; Jen Kok; Kristine Macartney; Jennifer MacLachlan; Cara Minney-Smith; David Smith; Nigel Stocks; Janette Taylor; Ian G Barr
Journal:  Euro Surveill       Date:  2020-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.